Chemoinformaics analysis of 24-Methylene-24-dihydrolanosterol acetate
| Molecular Weight | 482.793 | nRot | 6 |
| Heavy Atom Molecular Weight | 428.361 | nRig | 22 |
| Exact Molecular Weight | 482.412 | nRing | 4 |
| Solubility: LogS | -6.799 | nHRing | 0 |
| Solubility: LogP | 7.572 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 89 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 54 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 33 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 92.7208 |
| nHD | 0 | BPOL | 56.7772 |
| QED | 0.278 |
| Synth | 4.67 |
| Natural Product Likeliness | 3.283 |
| NR-PPAR-gamma | 0.444 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.964 |
| Pgp-sub | 0 |
| HIA | 0.011 |
| CACO-2 | -4.754 |
| MDCK | 0.0000104 |
| BBB | 0.126 |
| PPB | 0.969336 |
| VDSS | 2.234 |
| FU | 0.0173151 |
| CYP1A2-inh | 0.022 |
| CYP1A2-sub | 0.506 |
| CYP2c19-inh | 0.07 |
| CYP2c19-sub | 0.98 |
| CYP2c9-inh | 0.094 |
| CYP2c9-sub | 0.618 |
| CYP2d6-inh | 0.026 |
| CYP2d6-sub | 0.73 |
| CYP3a4-inh | 0.354 |
| CYP3a4-sub | 0.843 |
| CL | 5.502 |
| T12 | 0.005 |
| hERG | 0.005 |
| Ames | 0.016 |
| ROA | 0.022 |
| SkinSen | 0.021 |
| Carcinogencity | 0.019 |
| EI | 0.15 |
| Respiratory | 0.595 |
| NR-Aromatase | 0.305 |
| Antiviral | No |
| Prediction | 0.677521 |